annual CFO:
-$166.31M-$85.14M(-104.89%)Summary
- As of today (June 17, 2025), MLYS annual cash flow from operations is -$166.31 million, with the most recent change of -$85.14 million (-104.89%) on December 31, 2024.
- During the last 3 years, MLYS annual CFO has fallen by -$151.75 million (-1042.34%).
- MLYS annual CFO is now -6652.50% below its all-time high of -$2.46 million, reached on December 1, 2020.
Performance
MLYS Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$45.49M+$21.36M(+31.95%)Summary
- As of today (June 17, 2025), MLYS quarterly cash flow from operations is -$45.49 million, with the most recent change of +$21.36 million (+31.95%) on March 31, 2025.
- Over the past year, MLYS quarterly CFO has dropped by -$26.35 million (-137.67%).
- MLYS quarterly CFO is now -731.72% below its all-time high of -$5.47 million, reached on June 1, 2022.
Performance
MLYS quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$192.66M-$26.35M(-15.84%)Summary
- As of today (June 17, 2025), MLYS TTM cash flow from operations is -$192.66 million, with the most recent change of -$26.35 million (-15.84%) on March 31, 2025.
- Over the past year, MLYS TTM CFO has dropped by -$105.13 million (-120.09%).
- MLYS TTM CFO is now -2828.88% below its all-time high of -$6.58 million, reached on March 1, 2022.
Performance
MLYS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MLYS Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -104.9% | -137.7% | -120.1% |
| 3 y3 years | -1042.3% | -591.5% | -2828.9% |
| 5 y5 years | -6652.5% | - | - |
MLYS Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1042.3% | at low | -731.7% | +31.9% | -1499.3% | at low |
| 5 y | 5-year | -6652.5% | at low | -731.7% | +31.9% | -2828.9% | at low |
| alltime | all time | -6652.5% | at low | -731.7% | +31.9% | -2828.9% | at low |
MLYS Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$45.49M(-31.9%) | -$192.66M(+15.8%) |
| Dec 2024 | -$166.31M(+104.9%) | -$66.84M(+33.2%) | -$166.31M(+29.5%) |
| Sep 2024 | - | -$50.19M(+66.5%) | -$128.45M(+32.0%) |
| Jun 2024 | - | -$30.15M(+57.5%) | -$97.30M(+11.1%) |
| Mar 2024 | - | -$19.14M(-34.0%) | -$87.54M(+7.8%) |
| Dec 2023 | -$81.17M | -$28.98M(+52.3%) | -$81.17M(+30.1%) |
| Sep 2023 | - | -$19.03M(-6.6%) | -$62.38M(+23.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$20.39M(+59.6%) | -$50.34M(+42.1%) |
| Mar 2023 | - | -$12.78M(+25.4%) | -$35.42M(+21.2%) |
| Dec 2022 | -$29.22M(+100.7%) | -$10.19M(+45.8%) | -$29.22M(+53.5%) |
| Sep 2022 | - | -$6.99M(+27.8%) | -$19.04M(+58.0%) |
| Jun 2022 | - | -$5.47M(-16.9%) | -$12.05M(+83.1%) |
| Mar 2022 | - | -$6.58M | -$6.58M |
| Dec 2021 | -$14.56M(+491.1%) | - | - |
| Dec 2020 | -$2.46M | - | - |
FAQ
- What is Mineralys Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual CFO year-on-year change?
- What is Mineralys Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly CFO year-on-year change?
- What is Mineralys Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Mineralys Therapeutics?
- What is Mineralys Therapeutics TTM CFO year-on-year change?
What is Mineralys Therapeutics annual cash flow from operations?
The current annual CFO of MLYS is -$166.31M
What is the all time high annual CFO for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual cash flow from operations is -$2.46M
What is Mineralys Therapeutics annual CFO year-on-year change?
Over the past year, MLYS annual cash flow from operations has changed by -$85.14M (-104.89%)
What is Mineralys Therapeutics quarterly cash flow from operations?
The current quarterly CFO of MLYS is -$45.49M
What is the all time high quarterly CFO for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly cash flow from operations is -$5.47M
What is Mineralys Therapeutics quarterly CFO year-on-year change?
Over the past year, MLYS quarterly cash flow from operations has changed by -$26.35M (-137.67%)
What is Mineralys Therapeutics TTM cash flow from operations?
The current TTM CFO of MLYS is -$192.66M
What is the all time high TTM CFO for Mineralys Therapeutics?
Mineralys Therapeutics all-time high TTM cash flow from operations is -$6.58M
What is Mineralys Therapeutics TTM CFO year-on-year change?
Over the past year, MLYS TTM cash flow from operations has changed by -$105.13M (-120.09%)